Skip to main content
Search
Search
Toggle navigation
About Terumo India
Col 1
About Terumo India
Col 2
Dear Stakeholders
Who We Are
At a Glance
Terumo Group Identity
Col 3
Leadership Team
History
Terumo's Purpose
Response to COVID-19
Business Overview
Col 1
Business Overview
Col 2
TIS Division (Terumo Interventional Systems)
Cardiovascular Division (Terumo Cardiovascular)
Vascular Graft Division (Terumo Aortic)
Col 3
Life Care Solutions Division
Pharmaceutical Solutions Division
Sustainability
col 1
Sustainability
col 2
CSR Initiatives
CSR Policy & Committee
col 3
Award & Recognition
Creating a Diverse and Inclusive Workplace
Technology
col 1
Technology Overview
col 2
Basic Information
col 3
Stories - Our Technologies
News
Col 1-4
News
Col 2-2
Col 2-4
December 12, 2022
Financial
Notification of Completion of Acquisition and Cancellation of Own Shares (PDF 115.79 KB) (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation)
Col 3-4
December 8, 2022
Corporate
Ultimaster Drug Eluting Stent family (Terumo) first stent to receive the mention 1-month DAPT in the reimbursement conditions in France
Col 4-4
December 06, 2022
Corporate
Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
Global Network
Col 1
Global Network
Col 2
Japan
North America
South America
Col 3
EMEA
Greater China
Asia and Pacific
Home
Our Culture
Our Culture
Click Here To Know More
Contact
Us
Top
Top
